Several in vivo and in vitro studies using preclinical models of neurodegenerative diseases show that GLP-1R activation reduces the production of pro-inflammatory cytokines and immune cell infiltration in tissues (38, 40–42). The gene discussed is GLP1R; the disease is neurodegenerative disease.